Oroxcell

Oroxcell is an independent research organization (CRO) offering research services assessing the safety, toxicity and efficacy of active ingredients and finished formulations. Specialized in in-vitro testing, particularly in 3D Human Models, Oroxcell is developing its business on two fronts: Safety & efficacy testing: From screening to GLP Compliant studies, we provide well established In-vitro platform, 2D and 3D models, for performing routine and regulatory safety testing, ADME (Absorption, Distribution, Metabolism, and Elimination) and Toxicity (sensitization, phototoxicity and genotoxicity) tests, bioanalytical studies, for evaluating pharmaceuticals, medical devices, cosmetics, nutraceuticals, home care and chemical products. Research & Innovation: Oroxcell provides a wide...

3d models,adme,genotoxicity,skin sensitization,toxicology ,pre-clinical,pharmaceuticals,dermo-cosmetics,nutraceuticals,personal care ,biotechnology,medical devices,in-vitro testing,bioanalysis,mass spectrometry,pharmacology,efficacy,cytometry,qpcr,cell culture,and research

Oroxcell operates in the Biotechnology research industry.

Oroxcell's revenue is 11m - 100m

Oroxcell has 11 - 50 employees.